KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Asset Writedowns and Impairment (2023)

Historic Asset Writedowns and Impairment for Palvella Therapeutics (PVLA) over the last 1 years, with Q4 2023 value amounting to -$981000.0.

  • Palvella Therapeutics' Asset Writedowns and Impairment changed N/A to -$981000.0 in Q4 2023 from the same period last year, while for Sep 2024 it was $13.9 million, marking a year-over-year change of. This contributed to the annual value of $13.9 million for FY2023, which is N/A changed from last year.
  • Latest data reveals that Palvella Therapeutics reported Asset Writedowns and Impairment of -$981000.0 as of Q4 2023.
  • Palvella Therapeutics' 5-year Asset Writedowns and Impairment high stood at $14.9 million for Q3 2023, and its period low was -$981000.0 during Q4 2023.